Precision Neuroscience is innovating in the field of brain-computer interfaces (BCIs) by creating a device aimed at patients with paralysis. Cofounder Dr. Ben Rapoport clarifies a common myth regarding BCIs, asserting that significant brain data can be collected from the cortex rather than requiring deep brain penetration. The company has successfully received FDA clearance for part of its BCI technology and has raised $155 million since 2021, illustrating its progress and potential within the broader landscape of BCIs, which includes other notable firms like Neuralink.
Precision Neuroscience aims to develop less invasive brain-computer interfaces for paralysis patients by using a thin film that records brain activity from the cortex.
Dr. Ben Rapoport emphasizes that critical brain signals can be captured from the cortex without needing deep brain penetrations, contradicting common misconceptions about BCI invasiveness.
Collection
[
|
...
]